Intensity Therapeutics | 4:持股变动声明-高管 Talamo Joseph
Intensity Therapeutics | 4:持股变动声明-高管 Wesolowski John M
Intensity Therapeutics | SC 13G:超过5%持股股东披露文件-LFP Management, LLC(5.4%)
Intensity Therapeutics | 4:持股变动声明-高管 Wesolowski John M
Intensity Therapeutics | 4:持股变动声明-董事 DUBIN THOMAS I H
Intensity Therapeutics | 3:首次持股声明-董事 DUBIN THOMAS I H
Intensity Therapeutics | 4:持股变动声明-高管 Wesolowski John M
Intensity Therapeutics | 4:持股变动声明-董事 Leahy Emer
Intensity Therapeutics | 4:持股变动声明-董事 GOLDBERG MARK A
Intensity Therapeutics | 4:持股变动声明-董事 Donovan Daniel
Intensity Therapeutics | 4:持股变动声明-高管 BENDER LEWIS H
Intensity Therapeutics | SC 13G:超过5%持股股东披露文件-Lewis H. Bender(16.1%)
Intensity Therapeutics | 4:持股变动声明-首席财务官 Talamo Joseph
Intensity Therapeutics | 3:首次持股声明-首席财务官 Talamo Joseph
Intensity Therapeutics | 4:持股变动声明-高管 Wesolowski John M
Intensity Therapeutics | 3:首次持股声明-高管 Wesolowski John M
Intensity Therapeutics | 3:首次持股声明-高管 BENDER LEWIS H
Intensity Therapeutics | 3:首次持股声明-董事 GOLDBERG MARK A
Intensity Therapeutics | 3:首次持股声明-董事 Leahy Emer
Intensity Therapeutics | 3:首次持股声明-董事 Donovan Daniel
暂无数据
暂无数据